These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 20427837)

  • 1. Radiological and histological analysis of synthetic bone grafts in recurring giant cell tumour of bone: a retrospective study.
    Hattori H; Matsuoka H; Yamamoto K
    J Orthop Surg (Hong Kong); 2010 Apr; 18(1):63-7. PubMed ID: 20427837
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tissue response to porous hydroxyapatite ceramic in the human femoral head.
    Tachibana Y; Ninomiya S; Kim YT; Sekikawa M
    J Orthop Sci; 2003; 8(4):549-53. PubMed ID: 12898309
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Factors of local recurrence of giant cell tumor of long bone after treatment: plain radiographs, pathology and surgical procedures.
    Chanchairujira K; Jiranantanakorn T; Phimolsarnti R; Asavamongkolkul A; Waikakul S
    J Med Assoc Thai; 2011 Oct; 94(10):1230-7. PubMed ID: 22145509
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinical observation of surgical management for recurrent giant cell tumor of bone].
    Kong Q; Yang J; Xing R; Tu C; Zhou Y; Zhang H; Duan H
    Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2013 Jan; 27(1):36-40. PubMed ID: 23427489
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The evaluation of a biphasic calcium phosphate ceramic for use in grafting long-bone diaphyseal defects.
    Moore DC; Chapman MW; Manske D
    J Orthop Res; 1987; 5(3):356-65. PubMed ID: 3040949
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Composite ceramic bone graft substitute in the treatment of locally aggressive benign bone tumours.
    Schindler OS; Cannon SR; Briggs TW; Blunn GW
    J Orthop Surg (Hong Kong); 2008 Apr; 16(1):66-74. PubMed ID: 18453663
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effect of fibrin on osseointegration of bioactive glass-ceramic materials--experimental study].
    Urban K; Povýsil C; Spelda S
    Acta Chir Orthop Traumatol Cech; 2001; 68(3):168-75. PubMed ID: 11706539
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Giant cell tumor of the capitate.
    Angelini A; Mavrogenis AF; Ruggieri P
    Musculoskelet Surg; 2011 Apr; 95(1):45-8. PubMed ID: 21373912
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bisphosphonates reduce local recurrence in extremity giant cell tumor of bone: a case-control study.
    Tse LF; Wong KC; Kumta SM; Huang L; Chow TC; Griffith JF
    Bone; 2008 Jan; 42(1):68-73. PubMed ID: 17962092
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Giant cell tumour of the lower end of the radius--a new treatment modality.
    Mukherjee K; Chatterjee S; Bala SR
    J Indian Med Assoc; 1996 May; 94(5):170-1. PubMed ID: 8855568
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Radiological and clinical recurrence of giant-cell tumour of bone after the use of cement.
    Remedios D; Saifuddin A; Pringle J
    J Bone Joint Surg Br; 1997 Jan; 79(1):26-30. PubMed ID: 9020440
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanical properties of bone after implantation of apatite-wollastonite containing glass ceramic-fibrin mixture.
    Ono K; Yamamuro T; Nakamura T; Kokubo T
    J Biomed Mater Res; 1990 Jan; 24(1):47-63. PubMed ID: 2154498
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Techniques in recurrent giant cell tumour of the first metatarsal in adolescents - A rare report of 2 cases.
    Balaji GG; Roy AC; Justin SV
    Foot Ankle Surg; 2013 Mar; 19(1):e1-4. PubMed ID: 23337284
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adjuvant treatment with zoledronic acid after extensive curettage for giant cell tumours of bone.
    Gouin F; Rochwerger AR; Di Marco A; Rosset P; Bonnevialle P; Fiorenza F; Anract P
    Eur J Cancer; 2014 Sep; 50(14):2425-31. PubMed ID: 25088085
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The chemical composition of synthetic bone substitutes influences tissue reactions in vivo: histological and histomorphometrical analysis of the cellular inflammatory response to hydroxyapatite, beta-tricalcium phosphate and biphasic calcium phosphate ceramics.
    Ghanaati S; Barbeck M; Detsch R; Deisinger U; Hilbig U; Rausch V; Sader R; Unger RE; Ziegler G; Kirkpatrick CJ
    Biomed Mater; 2012 Feb; 7(1):015005. PubMed ID: 22287541
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Local recurrence after curettage treatment of giant cell tumors in peripheral bones: retrospective study by the GSF-GETO (French Sarcoma and Bone Tumor Study Groups).
    Gouin F; Dumaine V;
    Orthop Traumatol Surg Res; 2013 Oct; 99(6 Suppl):S313-8. PubMed ID: 23978709
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Application of mixed bone graft (autograft+allograft) in the management of giant cell tumor of bone.
    Datta NK; Ahamed SU; Miah MM; Nessa A
    Mymensingh Med J; 2010 Apr; 19(2):225-31. PubMed ID: 20395916
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Giant cell tumours in hand bones.
    Minhas MS; Mehboob G; Ansari I
    J Coll Physicians Surg Pak; 2010 Jul; 20(7):460-3. PubMed ID: 20642946
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Giant cell tumors of the bones of the hand.
    Athanasian EA; Wold LE; Amadio PC
    J Hand Surg Am; 1997 Jan; 22(1):91-8. PubMed ID: 9018620
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Giant cell tumor of bone. An evaluation of 87 patients].
    Tunn PU; Schlag PM
    Z Orthop Ihre Grenzgeb; 2003; 141(6):690-8. PubMed ID: 14679436
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.